Kaleo, maker of $4,100 overdose antidote, authorizes a generic version for just $178

Drug manufacturer Kaleo announced Wednesday it has authorized its subsidiary IJ Therapeutics to produce a largely identical version of its automated naloxone injector for a retail price of $178 for a kit, which, like the $4,100 brand-name version, contains two doses.

Drug manufacturer Kaleo announced Wednesday it has authorized its subsidiary IJ Therapeutics to produce a largely identical version of its automated naloxone injector for a retail price of $178 for a kit, which, like the $4,100 brand-name version, contains two doses. First responder groups and health departments will be offered the brand-name product Evzio at the same price. Kaleo says the generic will foster broader access to some Medicare beneficiaries. It will become available in mid-2019. "With approximately 130 people dying daily from opioid overdoses, we recognize that more needs to be done to improve access for patients," says Spencer Williamson, the company's president and CEO.